Structural racism and limited resources can pose barriers to type 2 diabetes care in Black patients. A Black physician and ...

Women with diabetes are at a higher risk of heart disease due to various factors such as hormonal imbalance and atypical ...

Glenmark Pharmaceuticals launches Empagliflozin, an SGLT2 inhibitor, in India under the brand name Glempa for glycemic ...

Alkem Laboratories launches generic empagliflozin in India as Empanorm, offering affordable treatment for diabetes and ...

New research suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with type 1 diabetes. The findings counter common assumptions that older adults would ...

Discover simple lifestyle changes backed by research that can significantly lower your type 2 diabetes risk without requiring ...

A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

A review published in Nutrients finds that ketogenic diets (KD) may offer superior benefits for weight loss, blood sugar control, and inflammation compared to other diets. Researchers also highlight ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

A new study examines the geographic and demographic connections between health and a lack of consistent access to food, ...

“We're really looking at… through the support of pharmacists in the community, through the support of registered dieticians, ...

A new study has revealed how diabetes can make the most aggressive form of breast cancer even more deadly, especially for patients at risk of brain metastases. The research, conducted by scientists at ...